Business Description
Biotech Acquisition Co
NAICS : 551112
SIC : 6719
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 2.47 | |||||
12-1 Month Momentum % | 1.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | 3.81 | |||||
ROA % | 3.48 | |||||
ROIC % | -1.62 | |||||
ROC (Joel Greenblatt) % | -37390 | |||||
ROCE % | -1.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 39.8 | |||||
PE Ratio without NRI | 39.8 | |||||
PB Ratio | 1.34 | |||||
EV-to-EBIT | -78.12 | |||||
EV-to-EBITDA | -78.12 | |||||
EV-to-FCF | -419.09 | |||||
Earnings Yield (Greenblatt) % | -1.28 | |||||
FCF Yield % | -0.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BIOTU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biotech Acquisition Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | - | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 10.16 | ||
14-Day RSI | - | ||
14-Day ATR ($) | 0.125714 | ||
20-Day SMA ($) | - | ||
12-1 Month Momentum % | 1.81 | ||
52-Week Range ($) | 8.73 - 11.1146 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biotech Acquisition Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biotech Acquisition Co Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Biotech Acquisition Co Frequently Asked Questions
What is Biotech Acquisition Co(BIOTU)'s stock price today?
When is next earnings date of Biotech Acquisition Co(BIOTU)?
Does Biotech Acquisition Co(BIOTU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |